arrow
Back
K

Kevan C. Herold

immunobiology

92H-index
439Paper Count
3.2WCitation Count
Published Papers 227
Publication Date
Tet2 modulates ER stress responses related to β-cell death and autoimmunity in diabetes
err2026-01-27
err0
errOAAI
errJinxiu Rui; Madhav Kothari; Romy Kursawe; Mahsa Nouri Barkestani; Romi Genosar; Pamela Clark; Michael L. Stitzel; Kevan C. Herold
errShare
errSave
CTLA-4 blockade shifts the B cell repertoire toward autoimmunity
err2025-11-17
err0
errOAAI
errCakan, Elif; Wang, Meng; Dai, Yile; Mirouse, Adrien; Villanueva-Pachas, Clarence Rachel; Bouis, Delphine; Boeckers, Joshua M.; Gera, Ruchi; Yraita, Sally; Clapp, Leslie; Perdigoto, Ana Luisa; Delmotte, Fabien R.; Massad, Christopher; Bacchiocchi, Antonietta; Ring, Aaron M.; Kluger, Yuval; Kluger, Harriet M.; Herold, Kevan C.; Meffre, Eric
errShare
errSave
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients
err2025-11-07
err0
errOAAI
errNoam Savion Gaiger; Michael E. Hurwitz; Navid Hafez; Harriet M. Kluger; Kevan C. Herold; Ana Luisa Perdigoto
errShare
errSave
The Pathogenesis of Type 1 Diabetes
err2025-11-01
err0
PREAI
errHerold, Kevan C.; Krischer, Jeffrey P.
errShare
errSave
Anti-CD3 mAb treatment reshapes CD8+T cells in the islets in autoimmune diabetes
err2025-11-01
err0
PREAI
errWu, Ying; Spurrell, Maxwell; Deng, Songyan; Barkestani, Mahsa Nouri; Herold, Kevan C.
errShare
errSave
Towards insulin independence in type 1 diabetes: Prospects for prevention and cure
err2025-11-01
err0
PREAI
errSydney, Guy I.; Perdigoto, Ana Luisa; Herold, Kevan C.
errShare
errSave
The Teplizumab Saga: The Challenge of Not Getting Lost in Clinical Translation
err2025-10-01
err2
PREAI
errChatenoud, Lucienne; Herold, Kevan C.; Bach, Jean-Francois; Bluestone, Jeffrey A.
errShare
errSave
Humoral determinants of checkpoint immunotherapy
errNature
IF48.5
err2025-07-23
err0
PREAI
errYile Dai; Lilach Aizenbud; Kai Qin; Matthew Austin; Jillian R. Jaycox; Joseph Cunningham; Eric Y. Wang; Lin Zhang; Suzanne Fischer; Sean M. Carroll; Helen van Aggelen; Yuval Kluger; Kevan C. Herold; Leon Furchtgott; Harriet M. Kluger; Aaron M. Ring
errShare
errSave
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study
err2025-05-12
err0
errOAAI
errQuandt, Zoe; Lucas, Anastasia; Liang, Samantha, I; Yang, Enjun; Stone, Samantha; Fadlullah, Muhammad Zaki Hidayatullah; Bayless, Nicholas L.; Marr, Sara Siebel; Thompson, Marshall A.; Padron, Lacey J.; Bucktrout, Samantha; Butterfield, Lisa H.; Tan, Aik Choon; Herold, Kevan C.; Bluestone, Jeffrey A.; Anderson, Mark S.; Spencer, Christine N.; Young, Arabella; Connolly, John E.
errShare
errSave
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts
err2025-01-06
err0
PREAI
errSosenko, Jay M.; Cuthbertson, David; Jacobsen, Laura M.; Redondo, Maria J.; Sims, Emily K.; Ismail, Heba M.; Herold, Kevan C.; Skyler, Jay S.; Nathan, Brandon M.; DPT TrialNet Study Groups
errShare
errSave
Reversing Diabetes With Your Own Cells: Closer to the Dream
err2024-12-13
err1
errOAAI
errGenosar, Romi; Coman, Magdalena Maria; Herold, Kevan C.
errShare
errSave
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes
err2024-12-13
err0
errOAAI
errRedondo, Maria J.; Cuthbertson, David; Steck, Andrea K.; Herold, Kevan C.; Oram, Richard; Atkinson, Mark; Brusko, Todd M.; Parikh, Hemang M.; Krischer, Jeffrey P.; Onengut-Gumuscu, Suna; Rich, Stephen S.; Sosenko, Jay M.
errShare
errSave
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
err2024-11-19
err0
errOAAI
errGalderisi, Alfonso; Sims, Emily K.; Evans-Molina, Carmella; Petrelli, Alessandra; Cuthbertson, David; Nathan, Brandon M.; Ismail, Heba M.; Herold, Kevan C.; Moran, Antoinette
errShare
errSave
Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop
err2024-08-21
err0
PREAI
errGreenbaum, Carla J.; Nepom, Gerald T.; Wood-Heickman, Lauren K.; Wherrett, Diane K.; Dimeglio, Linda A.; Herold, Kevan C.; Krischer, Jeffrey P.
errShare
errSave
Teplizumab induces persistent changes in the antigen- specific repertoire in individuals at risk for type 1 diabetes
err2024-08-13
err0
errOAAI
errLledo-Delgado, Ana; Preston-Hurlburt, Paula; Currie, Sophia; Clark, Pamela; Linsley, Peter S.; Long, S. Alice; Liu, Can; Koroleva, Galina; Martins, Andrew J.; Tsang, John S.; Herold, Kevan C.
errShare
errSave
Checkpoint Inhibitor-Induced Autoimmune Diabetes: An Autoinflammatory Disease
err2024-07-22
err1
PREAI
errQuandt, Zoe; Perdigoto, Ana; Anderson, Mark S.; Herold, Kevan C.
errShare
errSave
Experience with Teplizumab in the PROTECT Type 1 Diabetes (T1D) Study during the COVID-19 Pandemic
err2024-06-14
err0
PREAI
errGitelman, Stephen E.; Herold, Kevan C.; Simmons, Kimber M.; Sumnik, Zdenek; Knecht, Laura; Niemoeller, Elisabeth; Tian, Wei; Comer, Gail M.; Miller, Diana E.; Ramos, Eleanor L.
errShare
errSave
PROTECT Per-Protocol Analysis-Preserving β-Cell Function in Children and Adolescents with Newly Diagnosed Stage 3 Type 1 Diabetes (T1D)
err2024-06-14
err0
PREAI
errHerold, Kevan C.; Dayan, Colin; Chatenoud, Lucienne; Gitelman, Stephen E.; Sumnik, Zdenek; Simmons, Kimber M.; Szypowska, Agnieszka; Knecht, Laura; Niemoeller, Elisabeth; Tian, Wei; Ramos, Eleanor L.
errShare
errSave
Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention
err2024-06-14
err0
PREAI
errRedondo, Maria J.; Bundy, Brian N.; Parikh, Hemang M.; You, Lu; Triolo, Taylor M.; Ferrat, Lauric A.; Templeman, Erin; Tosur, Mustafa; Steck, Andrea; Gottlieb, Peter; Onengut-Gumuscu, Suna; Rich, Stephen S.; Oram, Richard A.; Herold, Kevan C.; Krischer, Jeffrey
errShare
errSave
Frequency of Single Autoantibody Positivity (SAB plus ) Varies by Race/Ethnicity and Area Deprivation Index in Individuals at Risk for Type 1 Diabetes (T1D)
err2024-06-14
err0
PREAI
errAddala, Ananta; Cabrera, Susanne M.; Cuthbertson, David D.; Libman, Ingrid; Tosur, Mustafa; Siller, Alejandro F.; Dimeglio, Linda A.; Herold, Kevan C.; Redondo, Maria J.; Ismail, Heba M.
errShare
errSave